Effects of Sodium-Glucose Co-transporter 2 Inhibitors on Inflammation
NCT06812429
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Inflammation
Interventions
DRUG:
Dapagliflozin (DAPA)
Sponsor
Washington University School of Medicine